{"schema_version":"secwatch.filing_event.v1","accession":"0001655759-24-000096","form_type":"8-K","ticker":"ARVN","cik":"0001655759","company_name":"ARVINAS, INC.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.451007+00:00","generated_at":"2026-06-01T03:54:44.463119+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arvinas amends Yale license, pays $14.95M upfront, $5M in 2025, eliminates minimum royalties","bullets":["Upfront $14.95M to Yale for amended license and collaboration income from Novartis deal on ARV-766 and AR-V7.","Additional $5M payment due on first anniversary (June 2025).","Contingent milestones up to $15M for approval of first two royalty products.","Ongoing low single-digit royalties on collaboration products; lower single-digit on meaningfully involved products.","Minimum annual royalties and annual fees eliminated; Yale releases all prior claims."],"urls":{"canonical":"https://secwatch.observer/filing/0001655759-24-000096","json":"https://secwatch.observer/filing/0001655759-24-000096.json","markdown":"https://secwatch.observer/filing/0001655759-24-000096.md","text":"https://secwatch.observer/filing/0001655759-24-000096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000165575924000096/0001655759-24-000096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000165575924000096/arvn-20240614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:54:44.463119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}